logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 7
  • 1
    O Brien, Michael
    Accountant born in September 1974
    Individual (9 offsprings)
    Officer
    2012-10-18 ~ 2020-01-27
    OF - Director → CIF 0
    Michael O'brien
    Born in September 1974
    Individual (9 offsprings)
    Person with significant control
    2016-04-06 ~ 2020-01-29
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Lacy, John
    Born in August 1976
    Individual (1 offspring)
    Officer
    2020-01-27 ~ now
    OF - Director → CIF 0
  • 3
    Mcdonagh, Keith
    Born in December 1974
    Individual (1 offspring)
    Officer
    2020-01-27 ~ now
    OF - Director → CIF 0
  • 4
    Hannon, John
    Born in December 1975
    Individual (3 offsprings)
    Officer
    2020-01-27 ~ now
    OF - Director → CIF 0
  • 5
    Van Der Vegt, David
    Born in March 1985
    Individual (2 offsprings)
    Officer
    2022-08-26 ~ now
    OF - Director → CIF 0
  • 6
    36, Merrion Square, Dublin 2, Dublin, Ireland
    Corporate (1 offspring)
    Person with significant control
    2020-01-29 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
  • 7
    PHARMENG LTD 08258301
    8, Eastgate Avenue, Little Island, Cork, Ireland
    Active Corporate (7 parents, 4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

PHARMENG LTD

Period: 2012-10-18 ~ now
Company number: 08258301
Registered name
PHARMENG LTD - now
Standard Industrial Classification
78109 - Other Activities Of Employment Placement Agencies
Brief company account
Average Number of Employees
4732024-01-01 ~ 2024-12-31
9352023-01-01 ~ 2023-12-31
Turnover/Revenue
9,972,717 GBP2024-01-01 ~ 2024-12-31
13,365,665 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-8,763,304 GBP2024-01-01 ~ 2024-12-31
-11,281,629 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
1,209,413 GBP2024-01-01 ~ 2024-12-31
2,084,036 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-1,177,383 GBP2024-01-01 ~ 2024-12-31
-1,682,014 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
32,030 GBP2024-01-01 ~ 2024-12-31
402,022 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
11,730 GBP2024-01-01 ~ 2024-12-31
308,057 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
24,738 GBP2024-12-31
Property, Plant & Equipment
23,117 GBP2024-12-31
33,489 GBP2023-12-31
Fixed Assets - Investments
2,341,422 GBP2024-12-31
Fixed Assets
2,389,277 GBP2024-12-31
33,489 GBP2023-12-31
Debtors
Current
1,685,607 GBP2024-12-31
2,484,490 GBP2023-12-31
Cash at bank and in hand
122,392 GBP2024-12-31
188,093 GBP2023-12-31
Current Assets
1,807,999 GBP2024-12-31
2,672,583 GBP2023-12-31
Net Current Assets/Liabilities
-1,328,583 GBP2024-12-31
1,015,475 GBP2023-12-31
Net Assets/Liabilities
1,060,694 GBP2024-12-31
1,048,964 GBP2023-12-31
Equity
Called up share capital
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2023-01-01
Retained earnings (accumulated losses)
1,060,693 GBP2024-12-31
1,048,963 GBP2023-12-31
740,906 GBP2023-01-01
Equity
1,060,694 GBP2024-12-31
1,048,964 GBP2023-12-31
740,907 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
11,730 GBP2024-01-01 ~ 2024-12-31
308,057 GBP2023-01-01 ~ 2023-12-31
Wages/Salaries
2,508,801 GBP2024-01-01 ~ 2024-12-31
3,128,998 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
278,171 GBP2024-01-01 ~ 2024-12-31
302,816 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
2,826,984 GBP2024-01-01 ~ 2024-12-31
3,482,727 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
32,030 GBP2024-01-01 ~ 2024-12-31
402,022 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
8,008 GBP2024-01-01 ~ 2024-12-31
94,475 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Development expenditure
30,850 GBP2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
6,112 GBP2024-12-31
Intangible Assets
Development expenditure
24,738 GBP2024-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
12,223 GBP2024-12-31
7,580 GBP2023-12-31
Office equipment
64,941 GBP2024-12-31
57,603 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
77,164 GBP2024-12-31
65,183 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
3,967 GBP2023-12-31
Office equipment
27,727 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
31,694 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings, Owned/Freehold
4,387 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
22,353 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
8,354 GBP2024-12-31
Office equipment
45,693 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
54,047 GBP2024-12-31
Property, Plant & Equipment
Furniture and fittings
3,869 GBP2024-12-31
3,613 GBP2023-12-31
Office equipment
19,248 GBP2024-12-31
29,876 GBP2023-12-31
Investments in Subsidiaries
2,341,422 GBP2024-12-31
Trade Debtors/Trade Receivables
Current
1,428,547 GBP2024-12-31
2,215,948 GBP2023-12-31
Prepayments/Accrued Income
Current
257,060 GBP2024-12-31
268,542 GBP2023-12-31
Bank Overdrafts
-29,522 GBP2024-12-31
-400,754 GBP2023-12-31
Cash and Cash Equivalents
92,870 GBP2024-12-31
-212,661 GBP2023-12-31
Bank Overdrafts
Current
29,522 GBP2024-12-31
400,754 GBP2023-12-31
Trade Creditors/Trade Payables
Current
122,708 GBP2024-12-31
175,562 GBP2023-12-31
Amounts owed to group undertakings
Current
2,570,010 GBP2024-12-31
679,542 GBP2023-12-31
Corporation Tax Payable
Current
114,265 GBP2024-12-31
93,965 GBP2023-12-31
Taxation/Social Security Payable
Current
114,919 GBP2024-12-31
228,491 GBP2023-12-31
Other Creditors
Current
111,000 GBP2024-12-31
Accrued Liabilities/Deferred Income
Current
74,158 GBP2024-12-31
78,794 GBP2023-12-31
Amount of value-added tax that is payable
Current
44,430 GBP2024-12-31
145,550 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2024-12-31
1 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1.002024-01-01 ~ 2024-12-31
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
1 GBP2023-01-01 ~ 2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
302,021 GBP2024-12-31
30,300 GBP2023-12-31
Between one and five year
561,000 GBP2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
863,021 GBP2024-12-31
30,300 GBP2023-12-31

Related profiles found in government register
  • PHARMENG LTD
    Info
    Registered number 08258301
    19-21 Great Tower Street, London EC3R 5AQ
    PRIVATE LIMITED COMPANY incorporated on 2012-10-18 (13 years 7 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-10-06
    CIF 0
  • PHARMENG LIMITED
    S
    Registered number 398764
    8 Eastgate Avenue, Little Island, Cork, Cork, Ireland, NONE
    IRELAND
    CIF 1
  • PHARMENG LTD
    S
    Registered number 08258301
    St. Magnus House, 3 Lower Thames Street, London, England, EC3R 6HE
    Private Limited Company in Companies House, England And Wales
    CIF 2
  • PHARMENG LIMITED
    S
    Registered number 398764
    8, Eastgate Avenue, Little Island, Co Cork, Ireland
    Limited Company in Companies Registry Ireland, Ireland
    CIF 3
child relation
Offspring entities and appointments 4
  • 1
    AMMEG ARVALEE ADVISORY LIMITED - now
    PE GLOBAL LTD
    - 2020-01-15 10132147
    St. Magnus House St. Magnus House, 3 Lower Thames Street, London, Ec3r 6he, England
    Dissolved Corporate (2 parents)
    Person with significant control
    2016-04-19 ~ 2020-01-13
    CIF 3 - Ownership of shares – 75% or more OE
    CIF 3 - Ownership of voting rights - 75% or more OE
  • 2
    AMMEG ARVALEE TECHNOLOGIES LIMITED
    - now 09790788
    LOCUM EXPRESS MEDICAL LTD
    - 2020-01-15 09790788
    St. Magnus House, 3 Lower Thames Street, London, England
    Dissolved Corporate (2 parents)
    Person with significant control
    2016-04-06 ~ 2020-01-13
    CIF 5 - Ownership of shares – 75% or more OE
    Officer
    2015-09-23 ~ dissolved
    CIF 1 - Secretary → ME
  • 3
    PHARMENG LTD
    08258301
    19-21 Great Tower Street, London, England
    Active Corporate (7 parents, 4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    CIF 4 - Ownership of shares – 75% or more OE
  • 4
    TRUST NURSE SERVICES LTD
    - now 09006266
    SJCS CONSULTANCY SERVICES LIMITED - 2015-02-11
    C/o Hill Dickinson, 1 St Pauls Square, Liverpool
    Liquidation Corporate (7 parents)
    Person with significant control
    2024-07-12 ~ now
    CIF 2 - Ownership of shares – 75% or more OE
    CIF 2 - Ownership of voting rights - 75% or more OE
    CIF 2 - Right to appoint or remove directors OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.